Unique immunologic patterns in fibromyalgia
Open Access
- 17 December 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Clinical Pathology
- Vol. 12 (1), 25
- https://doi.org/10.1186/1472-6890-12-25
Abstract
Background Fibromyalgia (FM) is a clinical syndrome characterized by chronic pain and allodynia. The diagnosis of FM has been one of exclusion as a test to confirm the diagnosis is lacking. Recent data highlight the role of the immune system in FM. Aberrant expressions of immune mediators, such as cytokines, have been linked to the pathogenesis and traits of FM. We therefore determined whether cytokine production by immune cells is altered in FM patients by comparing the cellular responses to mitogenic activators of stimulated blood mononuclear cells of a large number of patients with FM to those of healthy matched individuals. Methods Plasma and peripheral blood mononuclear cells (PBMC) were collected from 110 patients with the clinical diagnosis of FM and 91 healthy donors. Parallel samples of PBMC were cultured overnight in medium alone or in the presence of mitogenic activators; PHA or PMA in combination with ionomycin. The cytokine concentrations of IFN-γ, IL-5, IL-6, IL-8, IL-10, MIP-1β , MCP-1, and MIP1-α in plasma as well as in cultured supernatants were determined using a multiplex immunoassay using bead array technology. Results Cytokine levels of stimulated PBMC cultures of healthy control subjects were significantly increased as compared to matched non-stimulated PBMC cultures. In contrast, the concentrations of most cytokines were lower in stimulated samples from patients with FM compared to controls. The decreases of cytokine concentrations in patients samples ranged from 1.5-fold for MIP-1β to 10.2-fold for IL-6 in PHA challenges. In PMA challenges, we observed 1.8 to 4-fold decreases in the concentrations of cytokines in patient samples. Conclusion The cytokine responses to mitogenic activators of PBMC isolated from patients with FM were significantly lower than those of healthy individuals, implying that cell-mediated immunity is impaired in FM patients. This novel cytokine assay reveals unique and valuable immunologic traits, which, when combined with clinical patterns, can offer a diagnostic methodology in FM.Keywords
This publication has 36 references indexed in Scilit:
- Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patientsInflammopharmacology, 2012
- Systematic review with meta-analysis: cytokines in fibromyalgia syndromeBMC Musculoskeletal Disorders, 2011
- The Science of FibromyalgiaMayo Clinic Proceedings, 2011
- Improving the Recognition and Diagnosis of FibromyalgiaMayo Clinic Proceedings, 2011
- The Pathophysiology, Diagnosis and Treatment of FibromyalgiaPsychiatric Clinics of North America, 2010
- Diagnosis and Differential Diagnosis of FibromyalgiaAmerican Journal Of Medicine, 2009
- Integrated Review of the Association of Cytokines With Fibromyalgia and Fibromyalgia Core SymptomsBiological Research For Nursing, 2009
- Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patientsJournal of Neuroimmunology, 2008
- Reduced levels of antiinflammatory cytokines in patients with chronic widespread painArthritis & Rheumatism, 2006
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990